Predict your next investment

Non-Profit Foundation
HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
michaeljfox.org

See what CB Insights has to offer

Investments

50

Portfolio Exits

9

Partners & Customers

10

About The Michael J. Fox Foundation

The Michael J. Fox Foundation's goal is to help find the cure for Parkinson's disease.

The Michael J. Fox Foundation Headquarters Location

Church Street Station P.O. Box 780

New York, New York, 10008,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

The Michael J. Fox Foundation Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

The Michael J. Fox Foundation Rank

Latest The Michael J. Fox Foundation News

Michael J. Fox Foundation awards grant for digital predictor of PD progression

Aug 15, 2022

ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact customerservice@slackinc.com . Back to Healio The Michael J. Fox Foundation for Parkinson’s Research has awarded a research grant to health care technology company Koneksa to evaluate Parkinson’s disease progression using digital measures. According to a Koneksa release, the goal of the project is to predict stages of PD using distinct digital measures as classifiers and longitudinally model disease progression. Source: Adobe Stock. “There are no current diagnostics to detect progression in early PD or in the prodromal (pre-diagnostic) stage, and identifying any predictive digital biomarkers would be a meaningful addition for patients and physicians,” Chris Benko, CEO and founder of Koneksa, said in the release. The study will evaluate a retrospective Parkinson’s Progression Markers Initiative (PPMI) dataset from the Verily watch, comprised of digital measures (activity, gait, sleep) using Koneksa algorithms along with the application of specialized machine learning techniques, the release stated. The observational PPMI study is sponsored by the foundation. “The Michael J. Fox Foundation continues to fund research efforts aimed at improving the lives of people with Parkinson’s,” Samantha Hutten, PhD, the foundation’s director of translational research, said in the release. “We are proud to support the work of researchers at Koneksa investigating digital biomarkers to evaluate disease progression, as this is a critical unmet need.” In July 2022, Koneksa received its first research grant from the foundation, in collaboration with Northwestern University, to evaluate a measurement concept designed to objectively quantify the severity of PD symptoms, notably vocal abnormalities related to early stages of disease progression. Read more about

The Michael J. Fox Foundation Investments

50 Investments

The Michael J. Fox Foundation has made 50 investments. Their latest investment was in Koneksa as part of their Grant - II on August 8, 2022.

CBI Logo

The Michael J. Fox Foundation Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/8/2022

Grant - II

Koneksa

No

2

7/27/2022

Grant

ZyVersa Therapeutics

Yes

1

7/18/2022

Grant

EpicentRx

$0.5M

Yes

1

6/16/2022

Grant

Subscribe to see more

Subscribe to see more

10

5/4/2022

Grant - III

Subscribe to see more

Subscribe to see more

10

Date

8/8/2022

7/27/2022

7/18/2022

6/16/2022

5/4/2022

Round

Grant - II

Grant

Grant

Grant

Grant - III

Company

Koneksa

ZyVersa Therapeutics

EpicentRx

Subscribe to see more

Subscribe to see more

Amount

$0.5M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

1

10

10

The Michael J. Fox Foundation Portfolio Exits

9 Portfolio Exits

The Michael J. Fox Foundation has 9 portfolio exits. Their latest portfolio exit was Gain Therapeutics on March 18, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/18/2021

IPO

$99M

Public

4

9/21/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/8/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

10/5/2017

IPO

Subscribe to see more

$99M

Subscribe to see more

10

11/14/2014

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/18/2021

9/21/2020

9/8/2020

10/5/2017

11/14/2014

Exit

IPO

Acquired

Acquired

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

4

10

10

10

10

The Michael J. Fox Foundation Partners & Customers

10 Partners and customers

The Michael J. Fox Foundation has 10 strategic partners and customers. The Michael J. Fox Foundation recently partnered with WCG IRB on April 4, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

4/26/2022

Vendor

United States

1

4/14/2022

Partner

United States

Bent Water Brewing Company and Team Fox Collaborate with Breweries Around the Country to Launch Common Hope

LYNN , Massachusetts -- Bent Water Brewing will launch Common Hope , a nationwide collaborative initiative designed to raise funds and awareness for Parkinson 's disease .

1

1/26/2022

Partner

United States

1

10/6/2020

Partner

United States

Subscribe to see more

Subscribe to see more

10

7/16/2020

Partner

Denmark

Subscribe to see more

Subscribe to see more

10

Date

4/26/2022

4/14/2022

1/26/2022

10/6/2020

7/16/2020

Type

Vendor

Partner

Partner

Partner

Partner

Business Partner

Country

United States

United States

United States

United States

Denmark

News Snippet

Bent Water Brewing Company and Team Fox Collaborate with Breweries Around the Country to Launch Common Hope

LYNN , Massachusetts -- Bent Water Brewing will launch Common Hope , a nationwide collaborative initiative designed to raise funds and awareness for Parkinson 's disease .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

The Michael J. Fox Foundation Team

10 Team Members

The Michael J. Fox Foundation has 10 team members, including current Founder, Executive Vice President, Deborah Brooks.

Name

Work History

Title

Status

Deborah Brooks

Goldman Sachs Asset Management, and Goldman Sachs

Founder, Executive Vice President

Current

Alex Vannoni

Aetna, Atomic Management, Elemental Machines, Novartis, Cubist Pharmaceuticals, Lieber Institute for Brain Development, Instinct Health Science, Ogilvy & Mather, The Kraft Group, and Major League Baseball

Founder

Current

Todd Sherer

Chief Executive Officer

Current

Holly Teichholtz

Chief Marketing Officer

Current

Jim McNasby

Marsh, Mondelez International, Kraft Foods Group, and Davis Polk & Wardwell

Chief People Officer

Current

Name

Deborah Brooks

Alex Vannoni

Todd Sherer

Holly Teichholtz

Jim McNasby

Work History

Goldman Sachs Asset Management, and Goldman Sachs

Aetna, Atomic Management, Elemental Machines, Novartis, Cubist Pharmaceuticals, Lieber Institute for Brain Development, Instinct Health Science, Ogilvy & Mather, The Kraft Group, and Major League Baseball

Marsh, Mondelez International, Kraft Foods Group, and Davis Polk & Wardwell

Title

Founder, Executive Vice President

Founder

Chief Executive Officer

Chief Marketing Officer

Chief People Officer

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.